Related Experiment Video
Updated: Jul 19, 2026

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
A case of acute myocardial infarction during 5-fluorouracil infusion
Maria Laura Canale1, Andrea Camerini, Stefano Stroppa
1U.O. Malattie Cardiovascolari I Universitaria, Dipartimento Cardiotoracico, Italy. marialauracanale@katamail.com
Abstract:
Cardiac toxicity is an uncommon side-effect of 5-fluorouracil (5-FU) treatment, consisting mainly of chest pain episodes with or without electrocardiographic changes and dysrhythmias. Here, we describe the case of a 56-year-old male patient with a diagnosis of advanced colorectal cancer who developed an acute myocardial infarction during 5-FU infusion. The patient was not affected by prior heart disease and did not show any classic risk factors for coronary heart disease. Coronary angiography examination revealed no evidence of coronary stenosis, supporting the hypothesis of a coronary artery spasm related to 5-FU infusion. Given the great number of cancer patients receiving 5-FU containing chemotherapeutic regimens, this rare but severe cardiac side-effect may be observed in both cardiologic and oncologic clinical practice. We suggest a tight clinical monitoring of all patients receiving 5-FU infusions, even in those without a prior history of heart disease.
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
Acute Coronary Syndrome V: Nursing Management
Acute Coronary Syndrome I: Introduction
Imaging Studies for Cardiovascular System V: CT
Cardiac Catheterization IV: Nursing Management
Imaging Studies VII: Vascular Imaging

